Evaluating Japanese Patients With the Marfan Syndrome Using High-Throughput Microarray-Based Mutational Analysis of Fibrillin-1 Gene

• Published in: The American journal of cardiology 2011-12, Vol.108 (12), p.1801-1807
• Main Authors: Ogawa, Naomi, MD, PhD, Imai, Yasushi, MD, PhD, Takahashi, Yuji, MD, PhD, Nawata, Kan, MD, PhD, Hara, Kazuo, MD, PhD, Nishimura, Hiroshi, MD, PhD, Kato, Masayoshi, MD, PhD, Takeda, Norifumi, MD, PhD, Kohro, Takahide, MD, PhD, Morita, Hiroyuki, MD, PhD, Taketani, Tsuyoshi, MD, PhD, Morota, Tetsuro, MD, PhD, Yamazaki, Tsutomu, MD, PhD, Goto, Jun, MD, PhD, Tsuji, Shoji, MD, PhD, Takamoto, Shinichi, MD, PhD, Nagai, Ryozo, MD, PhD, Hirata, Yasunobu, MD, PhD
• Format: Article
• Language: English
• Subjects: Adult; Asian Continental Ancestry Group; Asian people; Biological and medical sciences; Cardiology. Vascular system; Cardiovascular; Criteria; Female; Genetic testing; Genotype & phenotype; Humans; Male; Marfan syndrome; Marfan Syndrome - diagnosis; Marfan Syndrome - genetics; Medical sciences; Microarray Analysis; Mutation; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/j.amjcard.2011.07.053

Marfan syndrome (MS) is an inherited connective tissue disorder, and detailed evaluations of multiple organ systems are required for its diagnosis. Genetic testing of the disease-causing fibrillin-1 gene (FBN1) is also important in this diagnostic scheme. The aim of this study was to define the clinical characteristics of Japanese patients with MS and enable the efficient and accurate diagnosis of MS with mutational analysis using a high-throughput microarray-based resequencing system. Fifty-three Japanese probands were recruited, and their clinical characteristics were evaluated using the Ghent criteria. For mutational analysis, an oligonucleotide microarray was designed to interrogate FBN1, and the entire exon and exon-intron boundaries of FBN1 were sequenced. Clinical evaluation revealed more pulmonary phenotypes and fewer skeletal phenotypes in Japanese patients with MS compared to Caucasians. The microarray-based resequencing system detected 35 kinds of mutations, including 23 new mutations. The mutation detection rate for patients who fulfilled the Ghent criteria reached 71%. Of note, splicing mutations accounted for 19% of all mutations, which is more than previously reported. In conclusion, this comprehensive approach successfully detected clinical phenotypes of Japanese patients with MS and demonstrated the usefulness and feasibility of this microarray-based high-throughput resequencing system for mutational analysis of MS.